A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1950
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes ; volume:81 ; number:9 ; day:8 ; month:5 ; year:2021 ; pages:1003-1030 ; date:6.2021
Drugs ; 81, Heft 9 (8.5.2021), 1003-1030, 6.2021
- Urheber
-
Andersen, Andreas
Knop, Filip Krag
Vilsbøll, Tina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-021-01499-w
- URN
-
urn:nbn:de:101:1-2021100820561741179545
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Andersen, Andreas
- Knop, Filip Krag
- Vilsbøll, Tina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oral Semaglutide: Dosage in Special Situations
A Review on the Efficacy and Safety of Oral Semaglutide
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
Semaglutide
Advances in GLP-1 treatment: focus on oral semaglutide
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews
The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
Design of self-emulsifying oral delivery systems for semaglutide: reverse micelles versus hydrophobic ion pairs
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
Oral Semaglutide: Dosage in Special Situations
A Review on the Efficacy and Safety of Oral Semaglutide
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
Semaglutide
Advances in GLP-1 treatment: focus on oral semaglutide
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews
The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
Design of self-emulsifying oral delivery systems for semaglutide: reverse micelles versus hydrophobic ion pairs
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
Oral Semaglutide: Dosage in Special Situations
A Review on the Efficacy and Safety of Oral Semaglutide
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
Semaglutide
Advances in GLP-1 treatment: focus on oral semaglutide
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews
The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
Design of self-emulsifying oral delivery systems for semaglutide: reverse micelles versus hydrophobic ion pairs